Pharmaceutical Executive-02-26-2009

Pharmaceutical Executive

Specialty Firms Shoot Down Big Money Bids

February 25, 2009

News Analysis

0

0

CV Therapeutics and Genetech rejected offers from big-name suitors. Are they playing hard to get or are they just not that into them?

Pfizer Pulls Two Late-stage Drugs from Development

February 25, 2009

News Analysis

0

0

A sign of the times or a rash decision? In an effort to curb unnecessary costs, Pfizer kills development of two late-stage products rather than sink more money into them.